Cancerase LLC aims to prevent cancer, support active treatment, and reduce recurrence risk with nutraceuticals and our AI-powered GPT knowledge system.
LYFBLEND LLC offers "Cancer Care Nutraceuticals," a specialized blend of herbs, vitamins, and natural substances formulated to combat cancer. With 45 years of research backing their effectiveness, these nutraceuticals have benefited patients worldwide. They can be used alone for cancer prevention or alongside traditional treatments such as chemotherapy.

Our "CANCERASE GPT" is an AI knowledge system for natural cancer healing, featuring thousands of pages of information on cancer nutraceuticals. Designed for use by both patients and professionals, it includes all the theoretical foundations we utilized in developing our Cancer Care Nutraceuticals.
There is no other product like "Cancer Care Nutraceuticals" and "CANCERASE GPT" in the world. With the booming AI sector and the popularity of nutritional products, our AI assists in the continual development and improvement of our "Cancer Care Nutraceuticals" blend.
Cancerase LLC is a partnership between experienced oncologist and cardiologist Dr. Dean Silver and seasoned AI engineer Andreas Kazmierczak. Both professionals have over 40 years of experience in their respective fields, combining their expertise to innovate in cancer care.
"Cancer Care Nutraceuticals" is a proprietary blend of nutraceuticals scientifically proven to kill cancer cells. This blend can be used with or without chemotherapy, depending on the patient's situation. Despite breakthroughs in non-chemotherapy oncology drugs, such as checkpoint inhibitors, oncologists still face limitations with chemotherapy and a few FDA-approved drugs.
We utilize AI methods and modern marketing strategies through social media and our AI GPT system to reach our target audience and promote our products effectively.
Our funding requirements over the next three years total $500,000.
The company projects strong financial growth, with significant revenue generation expected from the sales of our unique nutraceutical products and the utilization of our AI knowledge system.
We plan to sell the company after a strong expansion into a multimillion-dollar enterprise, capitalizing on our market position and innovative products.

Return on Investment (ROI) Analysis for Cancer Care Nutraceuticals and Cancerase GPT

 

1. Investment Overview

Cancerase LLC is seeking a total funding of $500,000 over the next three years for its nutritional product, "Cancer Care Nutraceuticals." The smallest investment accepted is $100,000. The product is expected to deliver a 10% return on investment (ROI) annually over the three-year investment period.

2. ROI Calculation

To understand the return on investment, we calculate the future value of the investment at a 10% annual return rate over three years.

Initial Investment (P): $100,000
Annual ROI (r): 10% or 0.10
Investment Period (t): 3 years

The formula to calculate the future value (FV) of the investment is: FV=P×(1+r)tFV = P \times (1 + r)^tFV=P×(1+r)t

3. Future Value Calculation

For an initial investment of $100,000: FV=100,000×(1+0.10)3FV = 100,000 \times (1 + 0.10)^3FV=100,000×(1+0.10)3 FV=100,000×(1.10)3FV = 100,000 \times (1.10)^3FV=100,000×(1.10)3 FV=100,000×1.331FV = 100,000 \times 1.331FV=100,000×1.331 FV=133,100FV = 133,100FV=133,100

The future value of an initial investment of $100,000 after three years at a 10% annual return is $133,100.

4. ROI Calculation

To calculate the ROI over three years, we use the formula: ROI=(FV−PP)×100%ROI = \left(\frac{FV - P}{P}\right) \times 100\%ROI=(PFV−P)×100%

For the investment: ROI=(133,100−100,000100,000)×100%ROI = \left(\frac{133,100 - 100,000}{100,000}\right) \times 100\%ROI=(100,000133,100−100,000)×100% ROI=(33,100100,000)×100%ROI = \left(\frac{33,100}{100,000}\right) \times 100\%ROI=(100,00033,100)×100% ROI=33.1%ROI = 33.1\%ROI=33.1%

The total ROI for a $100,000 investment over three years is 33.1%.

5. Summary

  • Initial Investment: $100,000
  • Annual Return Rate: 10%
  • Investment Period: 3 years
  • Future Value after 3 years: $133,100
  • Total ROI over 3 years: 33.1%

For an investor considering Cancerase LLC's nutritional product, an investment of $100,000 is expected to grow to $133,100 over three years, resulting in a total return of 33.1%.